Lung Diseases D008171

Diseases [C] » Respiratory Tract Diseases [C08] » Lung Diseases

Description

Pathological processes involving any part of the LUNG.   MeSH

Subtype Terms (27)

Acute Chest Syndrome
10 drugs (9 approved, 1 experimental)

alpha 1-Antitrypsin Deficiency
24 drugs (13 approved, 11 experimental)

Cystic Adenomatoid Malformation of Lung, Congenital
2 approved drugs

Cystic Fibrosis
293 drugs (140 approved, 153 experimental)

Hemoptysis
7 drugs (5 approved, 2 experimental)

Hepatopulmonary Syndrome
6 approved drugs

Hypertension, Pulmonary
156 drugs (99 approved, 57 experimental)

Lung Abscess
4 approved drugs

Lung Diseases, Fungal
4 drugs (3 approved, 1 experimental)

Lung Diseases, Interstitial
67 drugs (48 approved, 19 experimental)

Lung Diseases, Obstructive
23 drugs (18 approved, 5 experimental)

Lung Diseases, Parasitic
 

Lung, Hyperlucent
 

Lung Injury
11 drugs (9 approved, 2 experimental)

Lung Neoplasms
780 drugs (284 approved, 496 experimental)

Plasma Cell Granuloma, Pulmonary
 

Pneumonia
228 drugs (147 approved, 81 experimental)

Pulmonary Alveolar Proteinosis
7 drugs (4 approved, 3 experimental)

Pulmonary Atelectasis
10 approved drugs

Pulmonary Edema
16 drugs (14 approved, 2 experimental)

Pulmonary Embolism
71 drugs (52 approved, 19 experimental)

Pulmonary Eosinophilia
4 approved drugs

Pulmonary Veno-Occlusive Disease
3 approved drugs

Respiratory Distress Syndrome
194 drugs (106 approved, 88 experimental)

Scimitar Syndrome
 

Solitary Pulmonary Nodule
4 drugs (2 approved, 2 experimental)

Tuberculosis, Pulmonary
75 drugs (47 approved, 28 experimental)


Phase 3 Indicated Drugs (108)


Organization Involved with Phase 4 Indications (167)

Organization Involved with Phase 3 Indications (190)

Organization Involved with Phase 2 Indications (125)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.